Safety, Tolerability and Pharmacokinetics of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Chinese With Presbyopia
Clinical trial NCT06270030 · COMPLETED
Trial details
- NCT number
- NCT06270030
- Sponsor
- Corxel Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-04
- Primary completion
- 2024-04-10
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.